Page last updated: 2024-10-31

midazolam and Esophagotracheal Fistula

midazolam has been researched along with Esophagotracheal Fistula in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, B1
Ayub, A1
Bindra, A1
Gupta, S1
Mishra, B1

Other Studies

1 other study available for midazolam and Esophagotracheal Fistula

ArticleYear
Distal tracheoesophageal fistula in pediatric patient - an anesthetic challenge.
    Paediatric anaesthesia, 2014, Volume: 24, Issue:8

    Topics: Accidental Falls; Adjuvants, Anesthesia; Airway Management; Androstanols; Anesthesia, Inhalation; An

2014